These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence. Puccio I; Khan S; Butt A; Graham D; Sehgal V; Patel D; Novelli M; Lovat LB; Rodriguez-Justo M; Hamoudi RA Int J Exp Pathol; 2018 Feb; 99(1):10-14. PubMed ID: 29473241 [TBL] [Abstract][Full Text] [Related]
5. Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma. Coyle P; Mathew G; Game PA; Myers JC; Philcox JC; Rofe AM; Jamieson GG Br J Cancer; 2002 Aug; 87(5):533-6. PubMed ID: 12189552 [TBL] [Abstract][Full Text] [Related]
6. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation. Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575 [TBL] [Abstract][Full Text] [Related]
7. Surveillance in Barrett's esophagus: an audit of practice. Ajumobi A; Bahjri K; Jackson C; Griffin R Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878 [TBL] [Abstract][Full Text] [Related]
8. Endoscopic Raman spectroscopy enables objective diagnosis of dysplasia in Barrett's esophagus. Almond LM; Hutchings J; Lloyd G; Barr H; Shepherd N; Day J; Stevens O; Sanders S; Wadley M; Stone N; Kendall C Gastrointest Endosc; 2014 Jan; 79(1):37-45. PubMed ID: 23886354 [TBL] [Abstract][Full Text] [Related]
9. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus. Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633 [TBL] [Abstract][Full Text] [Related]
10. Trefoil Factor Expression in a Human Model of the Early Stages of Barrett's Esophagus. Dunn LJ; Jankowski JA; Griffin SM Dig Dis Sci; 2015 May; 60(5):1187-94. PubMed ID: 25424203 [TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754 [TBL] [Abstract][Full Text] [Related]
12. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]
13. Increasing diagnostic accuracy to grade dysplasia in Barrett's esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1. Karamchandani DM; Lehman HL; Ohanessian SE; Massé J; Welsh PA; Odze RD; Goldblum JR; Berg AS; Stairs DB Diagn Pathol; 2016 Feb; 11():23. PubMed ID: 26926447 [TBL] [Abstract][Full Text] [Related]
14. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182 [TBL] [Abstract][Full Text] [Related]
15. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Whitson MJ; Falk GW Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196 [TBL] [Abstract][Full Text] [Related]
16. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies? Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400 [TBL] [Abstract][Full Text] [Related]
17. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Cameron AJ; Carpenter HA Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304 [TBL] [Abstract][Full Text] [Related]
19. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. Canto MI; Setrakian S; Willis JE; Chak A; Petras RE; Sivak MV Endoscopy; 2001 May; 33(5):391-400. PubMed ID: 11396755 [TBL] [Abstract][Full Text] [Related]
20. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients. Lee RG Am J Surg Pathol; 1985 Dec; 9(12):845-52. PubMed ID: 2416226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]